ECOR electroCore

electroCore to Announce First Quarter March 31, 2025 Financial Results on Wednesday, May 7, 2025

electroCore to Announce First Quarter March 31, 2025 Financial Results on Wednesday, May 7, 2025

ROCKAWAY, N.J., April 30, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic technology company, announced today that it will report financial results for the first quarter ended March 31, 2025, after the close of the market on Wednesday, May 7, 2025.

Management will host a webinar at 4:30 PM EST to review the financial results and answer questions. Investors can access the webinar using the details below:

Wednesday, May 7, 4:30 PM EST

Dial-In: (646) 931-3860

Webinar ID: 885 4355 1292

Passcode: 419231

Registration Link: to participate and ask questions on the call.

About electroCore, Inc.

electroCore, Inc. and its subsidiaries (“electroCore” or the “Company”) is a commercial stage bioelectronic technology company whose mission is to improve health and quality of life through innovative non-invasive bioelectronic technologies.

For more information, visit .

Contact

ECOR Investor Relations

(973) 302-9253



EN
30/04/2025

Underlying

ECORelectroCore

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on electroCore

 PRESS RELEASE
Free
ECOR ELECTROCORE

electroCore Names Kelly Benning, Accomplished Healthcare Executive, as...

electroCore Names Kelly Benning, Accomplished Healthcare Executive, as SVP of Truvaga ROCKAWAY, N.J., Aug. 12, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that Kelly Benning has been hired as the Senior Vice President of Truvaga, effective July 21, 2025. Ms. Benning, who brings almost three decades of leadership experience across digital health, AI-enabled technologies, and consumer wellness, will lead electroCore’s consumer wellness division. Kelly Benning, electroCore's Senior Vice Preside...

August 12, 2025 1 EN
 PRESS RELEASE
Free
ECOR ELECTROCORE

electroCore Announces Second Quarter 2025 Financial Results

electroCore Announces Second Quarter 2025 Financial Results Net sales of $7.4 million increased 20% vs. Q2’2024; YTD net sales of $14.1 million increased 22% vs. first half of 2024 Cash, cash equivalents, restricted cash, and marketable securities of $7.4 million as of June 30, 2025  Company to host a conference call and webcast today, August 6, 2025, at 4:30 p.m. EDT ROCKAWAY, N.J., Aug. 06, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR) (“electroCore” or the “Company”), a commercial-stage bioelectronic technology company, today announced financial results for the three and...

August 6, 2025 1 EN
 PRESS RELEASE
Free
ECOR ELECTROCORE

electroCore Appoints James C. Theofilos to the Board of Directors

electroCore Appoints James C. Theofilos to the Board of Directors ROCKAWAY, N.J., Aug. 05, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that James C. Theofilos has been appointed to the Board of Directors, effective August 1, 2025. “I’m honored to have been appointed to the Board of Directors at electroCore,” said Mr. Theofilos. “For nearly two decades, the Theofilos family has deeply believed in the power of the vagus nerve and proudly supported electroCore as both an early investor and found...

August 5, 2025 1 EN
 PRESS RELEASE
Free
ECOR ELECTROCORE

electroCore to Announce Second Quarter June 30, 2025 Financial Results...

electroCore to Announce Second Quarter June 30, 2025 Financial Results on Wednesday, August 6, 2025 ROCKAWAY, N.J., July 23, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will report financial results for the second quarter ended June 30, 2025, after the close of the market on Wednesday, August 6, 2025. Management will host a webinar at 4:30 PM EDT to review the financial results and answer questions. Investors can access the webinar using the details below: Wednesday, August 6, 4:30 PM ...

July 23, 2025 1 EN
 PRESS RELEASE
Free
ECOR ELECTROCORE

electroCore to Participate in Upcoming Investor Conferences

electroCore to Participate in Upcoming Investor Conferences ROCKAWAY, N.J., July 22, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate in the following investor conferences. Needham 10th Annual Virtual MedTech and Diagnostics Conference, taking place virtually on Monday, August 11 and Tuesday, August 12, 2025. Management will host will host one-on-one meetings throughout both days. Canaccord Genuity 45th Annual Growth Conference, taking place in Massachusetts on Tues...

July 22, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch